Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bucci

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Pageof 6